Skip to main content
SpringerLink
Log in

Safety of second Pfizer-BioNTech COVID-19 vaccine booster

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yechezkel M, et al. Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study The Lancet Respiratory Medicine : 5 Dec 2022. Available from: URL: https://bit.ly/3F373Br

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Safety of second Pfizer-BioNTech COVID-19 vaccine booster. Reactions Weekly 1936, 12 (2022). https://doi.org/10.1007/s40278-022-29209-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-29209-4

Search

Navigation